Art
J-GLOBAL ID:201002215573920405
Reference number:10A0337182
Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study
中あるいは低リスクの成人急性骨髄性白血病に対する寛解後治療としての同種幹細胞移植と化学療法: JALSG AML97試験の結果
Author (14):
,
,
,
,
,
,
,
,
,
,
,
,
,
Material:
Volume:
91
Issue:
2
Page:
284-292
Publication year:
Mar. 2010
JST Material Number:
F0888A
ISSN:
0925-5710
CODEN:
IJHEEY
Document type:
Article
Article type:
原著論文
Country of issue:
Germany, Federal Republic of (DEU)
Language:
ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
JST classification (2):
JST classification
Category name(code) classified by JST.
Treatment for tumors in general
, Blood cell tumors(=neoplasms)
Reference (24):
-
OHNO, R. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group. Cancer. 1993, 71, 12, 3888-3895
-
KOBAYASHI, T. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. J Clin Oncol. 1996, 14, 1, 204-213
-
MIYAWAKI, S. No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia : the JALSG-AML92 study. Japan Adult Leukemia Study Group. Int J Hematol. 1999, 70, 2, 97-104
-
BUCHNER, T. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML) : a randomized trial of the German AML Cooperative Group. J Clin Oncol. 2003, 21, 24, 4496-4504
-
MOORE, JO. Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age : Cancer and Leukemia Group B Study 9222. Blood. 2005, 105, 9, 3420-3427
more...
Terms in the title (9):
Terms in the title
Keywords automatically extracted from the title.
,
,
,
,
,
,
,
,
Return to Previous Page